Prosecution Insights
Prosecution Insights
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
| HUMPHRIES, NICHOLAS ADAM | 1 | 33.3% | +78.6% |
| ALDARRAJI, ZAINAB MOHAMMED | 1 | 66.7% | +18.7% |
| FARAG, AMAL ALY | 1 | 67.8% | +38.0% |
| SULLIVAN, DENNIS JOHN | 1 | 61.1% | +47.4% |
| GRASER, JENNIFER E | 1 | 76.5% | +23.6% |
| CHATTIN, AMY MARIE | 1 | 72.9% | +43.5% |
| SALMON, KATHERINE D | 1 | 42.6% | +38.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18255885 | MICRO-DEVICE TRACKING AND VIZUALISATION SYSTEM | FARAG, AMAL ALY | 78d overdue |
| 18294577 | HYBRID PROMOTERS FOR GENE EXPRESSION IN MUSCLES AND IN THE CNS | MEYERING, SHABANA SHABBEER | — |
| 18551385 | EX-VIVO PROLIFERATION OF HUMAN PHAGOCYTIC CELLS | HUMPHRIES, NICHOLAS ADAM | — |
| 18248120 | COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS | GRASER, JENNIFER E | — |
| 17770304 | Immunotherapy Targeting Tumor Neoantigenic Peptides | CHATTIN, AMY MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18255885 | MICRO-DEVICE TRACKING AND VIZUALISATION SYSTEM | FARAG, AMAL ALY | 78d overdue |
| 18256706 | ULTRASOUND DEVICE TRACKING SYSTEM | ALDARRAJI, ZAINAB MOHAMMED | 8d overdue |
| 18294577 | HYBRID PROMOTERS FOR GENE EXPRESSION IN MUSCLES AND IN THE CNS | MEYERING, SHABANA SHABBEER | — |
| 18551385 | EX-VIVO PROLIFERATION OF HUMAN PHAGOCYTIC CELLS | HUMPHRIES, NICHOLAS ADAM | — |
| 18249830 | CIRCULATING MICROVESICLES EXPRESSING CARBONIC ANHYDRASE 9 FOR THE PROGNOSIS OF RENAL CELL CARCINOMA | SULLIVAN, DENNIS JOHN | — |
| 18248120 | COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS | GRASER, JENNIFER E | — |
| 17770304 | Immunotherapy Targeting Tumor Neoantigenic Peptides | CHATTIN, AMY MARIE | — |
| 16633183 | NEW SUBPOPULATIONS OF CANCER ASSOCIATED FIBROBLASTS AS PROGNOSIS MARKERS FOR IMMUNOTHERAPY TREATMENTS | SALMON, KATHERINE D | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1631 | 1 |
| 3797 | 1 |
| 3798 | 1 |
| 1642 | 1 |
| 1645 | 1 |
| 1643 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294577 | HYBRID PROMOTERS FOR GENE EXPRESSION IN MUSCLES AND IN THE CNS | MEYERING, SHABANA SHABBEER | 1635 | §103§112Other | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18551385 | EX-VIVO PROLIFERATION OF HUMAN PHAGOCYTIC CELLS | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18256706 | ULTRASOUND DEVICE TRACKING SYSTEM | ALDARRAJI, ZAINAB MOHAMMED | 3797 | §103Other | Final Rejection | 8d overdue | Pending | Jun 09, 2023 |
| 18255885 | MICRO-DEVICE TRACKING AND VIZUALISATION SYSTEM | FARAG, AMAL ALY | 3798 | §101§103 | Non-Final OA | 78d overdue | Pending | Jun 05, 2023 |
| 18249830 | CIRCULATING MICROVESICLES EXPRESSING CARBONIC ANHYDRASE 9 FOR THE PROGNOSIS OF RENAL CELL CARCINOMA | SULLIVAN, DENNIS JOHN | 1642 | §103 | Final Rejection | — | Pending | Apr 20, 2023 |
| 18248120 | COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS | GRASER, JENNIFER E | 1645 | §102§103§112 | Non-Final OA | — | Pending | Apr 06, 2023 |
| 17770304 | Immunotherapy Targeting Tumor Neoantigenic Peptides | CHATTIN, AMY MARIE | 1643 | §102§103§112 | Final Rejection | — | Pending | Apr 20, 2022 |
| 16633183 | NEW SUBPOPULATIONS OF CANCER ASSOCIATED FIBROBLASTS AS PROGNOSIS MARKERS FOR IMMUNOTHERAPY TREATMENTS | SALMON, KATHERINE D | 1682 | §112 | Final Rejection | — | Pending | Jan 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial